Selected abstracts will come to life in person at both conferences:
The VEINS Late-Breaking Clinical Trials – Sunday, November 2, 2025
VIVA Late-Breaking Clinical Trials – Monday & Tuesday, November 3 – 4, 2025
Research will be followed by live Q&A sessions and expert panel discussions
Get a first look at innovative findings in vascular medicine
Join interactive discussions with leading experts
Keep your finger on the pulse of emerging clinical trends, live in Las Vegas!
The abstract submission window is now officially closed. We appreciate the high volume of interest and scholarly contributions.
Each abstract was expected to include:
Trial name, purpose, and design (materials and methods)
Clear, original results and conclusions
Commitment that the findings had not been publicly presented prior
Submissions were evaluated on relevance to the field, methodological rigor, strength of data, and significance of endpoints.
If you have questions please contact Brita Thorne via e-mail: abstracts@viva-foundation.org
VIVA and The VEINS embargo Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on viva-foundation.org. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.
